Thursday, December 7, 2023
No Result
View All Result
No Result
View All Result

Akero Therapeutics (AKRO) Stock Forecast & Price Prediction

Estimation of the future price movement of Akero Therapeutics stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

Price target


Current $19.06

Concensus $45.00

Low $40.00

Median $45.00

High $50.00

Based on analysts projections #AKRO is expected to experience a positive growth trajectory over the next year.

The current average AKRO price target, as estimated by these analysts, is $45.00.

The predictions for the future AKRO stock price range from a low of $40.00 to a high of $50.00, highlighting the variability of market expectations for AKRO.

It is important to note that market fluctuations and unforeseen events can have an impact on these projections, so investors should always exercise caution and conduct thorough research before making any investment decisions.

AKRO stock forecasts by analyst

Analyst / firm Date Rating Price target Price when posted
Ed Arce
H.C. Wainwright 		October 11, 2023 Buy 40.00 15.04
Liisa Bayko
Evercore ISI 		September 13, 2022 Buy 50.00 29.05

Akero Therapeutics (AKRO) Fundamentals Checker

Financial metrics are used to evaluate financial stability which helps analysts determine if Akero Therapeutics is undervalued compared to its fair value. A company's financial health can strongly influence the stock forecast.

Neutral

Financial Scores

Updated on: 07/12/2023

Altman Z-Score: 11.5

Piotroski Score: 1.0

ESG Score

Updated on: 07/12/2023

Environmental: 60.9

Social: 59.7

Governance: 58.2

Financial Health

Updated on: 07/12/2023

DCF: Strong Buy

ROE: Sell

ROA: Sell

Debt to equity ratio: Neutral

Price to earnings ratio: Strong Sell

Price to book ratio: Strong Buy

AKRO Discounted Cash Flow

Updated on: 07/12/2023

$23.381
Discounted Cash Flow Value

$19.060
Current Price

AKRO Revenues by Segment

Updated on: 07/12/2023

No available data

Revenue from Contract with Customer, Excluding Assessed Tax

AKRO Revenues by Region

Updated on: 07/12/2023

No available data

AKRO Notes Due

Updated on: 07/12/2023

CIKExchangeTitle

There are no data to display

Akero Therapeutics (AKRO) Social Sentiments

Monitoring bullish and bearish sentiments towards Akero Therapeutics on Twitter and Stocktwits could help to forecast an upward or downward trend in Akero Therapeutics stock price.

Positive Stock Forecast: Akero Therapeutics' Potential in Metabolic Disease Treatments

Akero Therapeutics is a clinical-stage biopharmaceutical company that operates in the biotechnology sector. n The company is listed on the NASDAQ stock exchange under the ticker symbol AKRO. n Akero Therapeutics specializes in developing and commercializing treatments for serious metabolic diseases. The company's lead product candidate, AKR-001, is a potential treatment for non-alcoholic steatohepatitis (NASH), a severe form of liver... Read more

Akero Therapeutics: A Stock Prediction Analysis in the Promising Biotech Sector

The biotechnology sector is one of the most promising areas in the stock market as it has been expanding its boundaries into various fields over the years. With innovations and breakthroughs in the fields of pharmaceuticals, genetic engineering, and medical technology, many biotech companies have become attractive investments for long-term investors. One such company is Akero Therapeutics, which operates within... Read more
No Result
View All Result

© 2023 Best Stocks